Dr Reddy’s And Alvotech Team Up On Keytruda Rival

Pembrolizumab Partnership Follows Deal On Denosumab

 
• By Dave Wallace
  
Dr Reddy’s and Alvotech have allied on a further biosimilar (Shutterstock)

More from Deals

More from Strategy